BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella
The X‐linked inhibitor of apoptosis protein (XIAP) is a potent caspase inhibitor, best known for its anti‐apoptotic function in cancer. During apoptosis, XIAP is antagonized by SMAC, which is released from the mitochondria upon caspase‐mediated activation of BID. Recent studies suggest that XIAP is...
Saved in:
Published in | The EMBO journal Vol. 33; no. 19; pp. 2171 - 2187 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.10.2014
BlackWell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The X‐linked inhibitor of apoptosis protein (XIAP) is a potent caspase inhibitor, best known for its anti‐apoptotic function in cancer. During apoptosis, XIAP is antagonized by SMAC, which is released from the mitochondria upon caspase‐mediated activation of BID. Recent studies suggest that XIAP is involved in immune signaling. Here, we explore XIAP as an important mediator of an immune response against the enteroinvasive bacterium Shigella flexneri, both in vitro and in vivo. Our data demonstrate for the first time that Shigella evades the XIAP‐mediated immune response by inducing the BID‐dependent release of SMAC from the mitochondria. Unlike apoptotic stimuli, Shigella activates the calpain‐dependent cleavage of BID to trigger the release of SMAC, which antagonizes the inflammatory action of XIAP without inducing apoptosis. Our results demonstrate how the cellular death machinery can be subverted by an invasive pathogen to ensure bacterial colonization.
Synopsis
XIAP is an essential mediator for the anti‐bacterial immune response against the Gram‐negative enteroinvasive bacterium Shigella flexneri. Shigella escapes this immune response by involving the calpain‐mediated activation of BID, which leads to the release of mitochondrial SMAC. Cytosolic SMAC antagonizes XIAP and dampens the immunity against Shigella.
XIAP is a crucial component of the pro‐inflammatory response against Shigella.
Shigella induces the activation of calpain, which cleaves and activates BID.
Activated BID induces the release of mitochondrial SMAC in Shigella‐infected cells.
Cytosolic SMAC antagonizes XIAP and dampens the anti‐bacterial inflammatory signalling.
Invasive Shigella bacteria co‐opt the mitochondrial XIAP antagonist SMAC in ways that selectively decrease antibacterial inflammatory responses without triggering host cell apoptosis. |
---|---|
Bibliography: | ark:/67375/WNG-KQ8WZGK2-C istex:079055DE9A1C97816EA198AEA41AC0EB6A7BF860 Deutsche Forschungsgemeinschaft (DFG) - No. SFB670 Supplementary FiguresReview Process FileSource Data for Figure 2Source Data for Figure 3Source Data for Figure 4Source Data for Figure 5Source Data for Figure 6 ArticleID:EMBJ201387244 Subject Categories Microbiology, Virology & Host Pathogen Interaction |
ISSN: | 0261-4189 1460-2075 |
DOI: | 10.15252/embj.201387244 |